Guardant Health Cash Flow Statement
NASDAQ: GHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Guardant Health free cash flow
In fiscal 2025, Guardant Health generated -$184.8 million of operating cash flow and spent $48.3 million on capital expenditures. That left free cash flow of -$233.1 million, a free-cash-flow margin of -23.7% of revenue. Guardant Health returned $45.0 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
Guardant Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -416.28M | -436.37M | -479.45M | -654.59M | -384.77M | -246.28M | -67.85M | -84.26M | -83.22M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 39.74M | 42.39M | 42.88M | 35.96M | 22.27M | 16.07M | 11.41M | 7.14M | 5.21M |
| Stock-Based Compensation | 166.22M | 140.41M | 90.76M | 94.69M | 151.45M | 144.11M | 16.95M | 6.85M | 3.67M |
| Change in Working Capital | -23.30M | -14.24M | 1.06M | 1.02M | -45.08M | -43.91M | -15.73M | -7.13M | -12.23M |
| Operating Cash Flow | -184.76M | -239.86M | -324.98M | -309.46M | -209.02M | -103.93M | -47.13M | -72.19M | -72.23M |
| Capital Expenditures | -48.31M | -35.09M | -20.49M | -77.46M | -75.03M | -36.17M | -18.72M | -20.20M | -6.68M |
| Investing Cash Flow | -627.20M | -261.31M | 840.25M | 149.82M | -63.16M | -617.09M | -317.57M | -153.03M | -170.42M |
| Share Repurchases | -45.01M | 0 | 0 | — | — | 0 | 0 | -172.00K | -7.22M |
| Financing Cash Flow | 671.13M | -996.00K | 477.38M | -189.09M | -66.82M | 1.41B | 367.30M | 293.16M | 281.66M |
| Net Change in Cash | -140.34M | -503.93M | 991.74M | -350.34M | -340.69M | 689.75M | 2.68M | 67.95M | 39.01M |
| Free Cash Flow | -233.07M | -274.94M | -345.46M | -386.92M | -284.05M | -140.10M | -65.85M | -92.39M | -78.92M |
This table shows 9 annual periods of Guardant Health's cash flow statement, from FY 2025 back to FY 2017, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GH's reporting calendar. What is a cash flow statement?